Pharmacokinetics, safety and efficacy of pegfilgrastim in dose-dense, sequential adjuvant chemotherapy for patients with breast cancer (BC)

13546 Background: BC Patients undergoing adjuvant dose dense chemotherapy suffer high risk of febrile neutropenia (FN) due to a shortened intertreatment interval. Primary administration of Pegfilgr...